A change in FDA policy could effectively remove Mutual Pharmaceutical v. Bartlett's immunization of generic drug manufacturers.
Torts Today: Generic drug mfrs should have same safety warning duty as brand name patentees - New England Journal of Medicine:
'via Blog this'
No comments:
Post a Comment